These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19307544)

  • 21. Facial anatomy.
    Bentsianov B; Blitzer A
    Clin Dermatol; 2004; 22(1):3-13. PubMed ID: 15158538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An initial assessment of the systemic pharmacokinetics of botulinum toxin.
    Ravichandran E; Gong Y; Al Saleem FH; Ancharski DM; Joshi SG; Simpson LL
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1343-51. PubMed ID: 16782822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chapter 27: Neural plasticity after nerve injury and regeneration.
    Navarro X
    Int Rev Neurobiol; 2009; 87():483-505. PubMed ID: 19682656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysport: pharmacological properties and factors that influence toxin action.
    Pickett A
    Toxicon; 2009 Oct; 54(5):683-9. PubMed ID: 19332087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Pharmacology of Botulinum Toxin Drugs.
    Dressler D
    Handb Exp Pharmacol; 2021; 263():93-106. PubMed ID: 32886157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical relevance of botulinum toxin antibodies].
    Dressler D
    Nervenarzt; 2008 Jun; 79 Suppl 1():36-40. PubMed ID: 18927965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central mechanisms I: plasticity of central pathways.
    Chen CY; Joad JP; Bric J; Bonham AC
    Handb Exp Pharmacol; 2009; (187):187-201. PubMed ID: 18825341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A; Mayer NH; Elia AE; Albanese A
    Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies, reports say botulinum toxins may have effects beyond injection site.
    Kuehn BM
    JAMA; 2008 May; 299(19):2261-3. PubMed ID: 18492959
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance.
    Zheng P
    Prog Neurobiol; 2009 Oct; 89(2):134-52. PubMed ID: 19595736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manduca sexta (Lepidoptera: Sphingidae) cadherin fragments function as synergists for Cry1A and Cry1C Bacillus thuringiensis toxins against noctuid moths Helicoverpa zea, Agrotis ipsilon and Spodoptera exigua.
    Abdullah MA; Moussa S; Taylor MD; Adang MJ
    Pest Manag Sci; 2009 Oct; 65(10):1097-103. PubMed ID: 19489014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Facial anatomy and botulinum toxin: the muscular balances].
    Trevidic P; Cauchois R; Ingallina F
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Can the botulinum toxin prevent aging?].
    Le Louarn C
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S92-103. PubMed ID: 19576493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Controversy: botulinum toxin, does it prevent cutaneous aging?].
    Cohen-Letessier A
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction.
    Kitamura Y; Matsuka Y; Spigelman I; Ishihara Y; Yamamoto Y; Sonoyama W; Kamioka H; Yamashiro T; Kuboki T; Oguma K
    Neuroscience; 2009 Apr; 159(4):1422-9. PubMed ID: 19409226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
    Gassia V; Beylot C; Béchaux S; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical rhinoplasty: rationale for atraumatic nasal modelling using botulinum toxin and fillers].
    Braccini F; Dohan Ehrenfest DM
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):233-8. PubMed ID: 19408501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local calcium-dependent mechanisms determine whether a cut axonal end assembles a retarded endbulb or competent growth cone.
    Kamber D; Erez H; Spira ME
    Exp Neurol; 2009 Sep; 219(1):112-25. PubMed ID: 19442660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.